Breaking News

Forge Biologics to Expand Manufacturing Facility

Site in Columbus, OH will increase to over 200,000 square feet backed by $80mn in financing to accelerate CDMO expansion.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Forge Biologics, a gene therapy-focused contract development and manufacturing organization (CDMO), announced today 2022 manufacturing expansion plans to meet the growing demand for gene therapy manufacturing. The expansion will coincide with an accelerated increase in headcount and expansion of The Hearth facility in Columbus, Ohio, both aided by continued investments in the company. Forge has entered into a secured financing agreement with MidCap Financial that provides up to $80 million of...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters